Mining Public Domain Data to Develop Selective DYRK1A Inhibitors.

ABSTRACT

Kinases represent one of the most intensively pursued groups of targets in modern-day drug discovery. Often it is desirable to achieve selective inhibition of the kinase of interest over the remaining ∼500 kinases in the human kinome. This is especially true when inhibitors are intended to be used to study the biology of the target of interest. We present a pipeline of open-source software that analyzes public domain data to repurpose compounds that have been used in previous kinase inhibitor development projects. We define the dual-specificity tyrosine-regulated kinase 1A (DYRK1A) as the kinase of interest, and by addition of a single methyl group to the chosen starting point we remove glycogen synthase kinase ß (GSK3ß) and cyclin-dependent kinase (CDK) inhibition. Thus, in an efficient manner we repurpose a GSK3ß/CDK chemotype to deliver 8b, a highly selective DYRK1A inhibitor.